Enrico Zelin Selected Research

Halo Nevus

12/2021

Regression of nevi, vitiligo-like depigmentation and halo phenomenon may indicate response to immunotherapy and targeted therapy in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enrico Zelin Research Topics

Disease

3	Melanoma (Melanoma, Malignant) 06/2022 - 01/2021
3	Basal Cell Carcinoma (Rodent Ulcer) 01/2022 - 01/2021
2	Skin Neoplasms (Skin Cancer) 06/2022 - 01/2021
2	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2022 - 01/2022
2	Vitiligo 12/2021 - 10/2020
1	Prurigo 05/2022
1	Atopic Dermatitis (Atopic Eczema) 05/2022
1	Inflammation (Inflammations) 05/2022
1	Basosquamous Carcinoma 01/2022
1	Halo Nevus 12/2021
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Nevus (Nevi) 12/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Merkel Cell Carcinoma 01/2021
1	Discitis 01/2020

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 05/2022 - 01/2022
2	sonidegibIBA 01/2022 - 09/2021
1	dupilumabIBA 05/2022
1	Interleukin-4 Receptor alpha SubunitIBA 05/2022
1	Interleukin-13IBA 05/2022
1	Monoclonal AntibodiesIBA 05/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2022
1	InterleukinsIBA 05/2022
1	dabrafenibIBA 12/2021
1	pembrolizumabIBA 12/2021
1	Interleukin-17 (Interleukin 17)IBA 12/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021
1	trametinibIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Adalimumab (Humira)FDA Link 01/2020

Therapy/Procedure

3	Immunotherapy 06/2022 - 01/2021
3	Therapeutics 12/2021 - 01/2021
1	Cryotherapy (Therapy, Cold) 05/2022
1	Neoadjuvant Therapy 01/2021
1	Phototherapy (Light Therapy) 10/2020